Company / Inventory
Catalyst Pharmaceuticals Partners, Inc. Inventory History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$37.2M
FY2025
5-year range
$6.8M / $37.2M
FY2021-FY2025
Trend
+90.2%
vs FY2024
Sector context
#64 of 105
Health Care
What the data says
At $37M, Catalyst Pharmaceuticals Partners, Inc.'s inventory ranks #64 of 105 in the Health Care sector. Inventory has increased for 3 consecutive years, from $7M in FY2022 to $37M in FY2025.
Based on SEC 10-K filings.
$37M in FY2025 with a 5-year CAGR of +51.5%.
Improved from $16M to $37M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +76.1%
- 5-Year CAGR
- +51.5%
- 10-Year CAGR
- -
Sector benchmark
#64 of 105 in Health CareTop 61% of 105This company $37.2M Sector average $885.3M
▼
-95.8% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s inventory has grown for 3 consecutive years.
- 5-year CAGR of +51.5%, indicating consistent growth.
- In FY2025, inventory increased 90.2% year-over-year.
- Ranks #64 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.2M | +90.2% |
| FY2024 | $19.5M | +24.9% |
| FY2023 | $15.6M | +129.9% |
| FY2022 | $6.8M | -13.5% |
| FY2021 | $7.9M | +69.2% |
| FY2020 | $4.7M | +137.7% |
| FY2019 | $2.0M | +3393.5% |
| FY2018 | $56.0K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026